Bharat Parenter.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE365Y01019
  • NSEID:
  • BSEID: 541096
INR
1,335.15
-48.8 (-3.53%)
BSENSE

May 25

BSE+NSE Vol: 521

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002949,
    "name": "Bharat Parenter.",
    "stock_name": "Bharat Parenter.",
    "full_name": "Bharat Parenterals Ltd",
    "name_url": "stocks-analysis/bharat-parenter",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,335.15",
    "chg": -48.8,
    "chgp": "-3.53%",
    "dir": -1,
    "prev_price": "1,383.95",
    "mcapval": "954.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 541096,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE365Y01019",
    "curr_date": "May 25",
    "curr_time": "",
    "bse_nse_vol": 521,
    "exc_status": "Active",
    "traded_date": "May 25, 2026",
    "traded_date_str": "2026 05 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bharat-parenter-1002949-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bharat Parenterals Gains 10.53%: 2 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-parenterals-gains-1053-2-key-factors-driving-the-weeks-momentum-4008185",
        "imagepath": "",
        "date": "2026-05-23 13:00:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>18 May:</strong> Stock closes at Rs.1,266.55 with mixed technical signals amid mildly bullish momentum</p>\n                    <p><strong>19 May:</strong> Q4 FY26 results reveal mounting losses and operational turmoil</p>\n                    <p><strong>21 May:</strong> Sharp price jump to Rs.1,320.90 (+5.20%) on improving technical outlook</p>\n                    <p><strong>22 May:</strong> Week closes at Rs.1,383.95 (+4.77%), outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,252.05</div></div>\n                    <div class=\"stat-it..."
      },
      {
        "title": "Are Bharat Parenterals Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-bharat-parenterals-ltd-latest-results-good-or-bad-3999564",
        "imagepath": "",
        "date": "2026-05-19 19:21:30",
        "description": "Bharat Parenterals Ltd's latest financial results for Q4 FY26 reflect a company facing significant operational challenges. The consolidated net loss for the quarter stood at ₹4.80 crores, which represents a slight improvement in terms of a lower loss compared to the previous quarter. However, this figure indicates persistent difficulties in achieving profitability. \n\nNet sales for the quarter were reported at ₹99.62 crores, showing a sequential increase of 52.81% from the previous quarter, but this figure is still 4.19% lower than the same quarter last year. This revenue volatility suggests inconsistent demand and potential issues with customer retention in the pharmaceutical sector.\n\nThe operating margin, excluding other income, was negative at -0.53%, marking the lowest level in recent quarters. This reflects a significant decline from the previous year's operating margin of 11.88%, indicating severe pres..."
      },
      {
        "title": "Bharat Parenterals Q4 FY26: Mounting Losses and Operational Turmoil Signal Deeper Structural Crisis",
        "link": "https://www.marketsmojo.com/news/result-analysis/bharat-parenterals-q4-fy26-mounting-losses-and-operational-turmoil-signal-deeper-structural-crisis-3999105",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BharatParentera_quaterlyResult_3999105.png",
        "date": "2026-05-19 09:51:31",
        "description": "Bharat Parenterals Ltd., a Gujarat-based pharmaceutical manufacturer, reported a consolidated net loss of ₹4.80 crores for Q4 FY26 ended March 2026, extending a troubling pattern of persistent losses across the fiscal year. The micro-cap company, with a market capitalisation of ₹845.99 crores, saw its stock decline 3.08% to ₹1,227.50 following the results announcement, reflecting investor concern over deteriorating operational metrics and negative operating margins."
      },
      {
        "title": "Bharat Parenterals Ltd Shows Mixed Technical Signals Amid Mildly Bullish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-parenterals-ltd-shows-mixed-technical-signals-amid-mildly-bullish-momentum-3996137",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BharatParentera_technicaldot_3996137.png",
        "date": "2026-05-18 08:02:59",
        "description": "Bharat Parenterals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced outlook for investors amid recent price gains and sector dynamics."
      },
      {
        "title": "Bharat Parenterals Gains 3.25%: 3 Key Factors Driving the Week’s Mixed Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-parenterals-gains-325-3-key-factors-driving-the-weeks-mixed-momentum-3994248",
        "imagepath": "",
        "date": "2026-05-16 12:05:50",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>11 May:</strong> Stock opens strong at Rs.1,246.35 (+2.78%) amid technical momentum shift</p>\n                    <p><strong>12 May:</strong> Technical momentum shifts to mildly bullish despite Sensex decline</p>\n                    <p><strong>14 May:</strong> Stock dips 2.03% as technical indicators show mixed signals</p>\n                    <p><strong>15 May:</strong> Downgrade to Strong Sell announced; technical momentum shifts sideways</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,212.65</div></div>\n                    <div class=\"stat-item\"><div..."
      },
      {
        "title": "Bharat Parenterals Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weakness",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-parenterals-ltd-downgraded-to-strong-sell-amid-technical-and-fundamental-weakness-3992146",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BharatParentera_mojoScore_3992146.png",
        "date": "2026-05-15 08:17:05",
        "description": "Bharat Parenterals Ltd has been downgraded from a Sell to a Strong Sell rating as of 14 May 2026, reflecting deteriorating technical indicators and weak fundamental performance. The micro-cap pharmaceutical company’s Mojo Score has declined to 23.0, signalling heightened risk for investors amid sideways technical trends and disappointing financial results."
      },
      {
        "title": "Bharat Parenterals Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-parenterals-ltd-technical-momentum-shifts-amid-mixed-market-signals-3992062",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BharatParentera_technicaldot_3992062.png",
        "date": "2026-05-15 08:00:36",
        "description": "Bharat Parenterals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade to a Strong Sell rating with a Mojo Score of 23.0, the stock’s technical indicators present a complex picture, reflecting both bullish and bearish signals across different timeframes."
      },
      {
        "title": "Bharat Parenterals Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-parenterals-ltd-technical-momentum-shifts-to-mildly-bullish-amid-mixed-indicators-3986623",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BharatParentera_technicaldot_3986623.png",
        "date": "2026-05-12 08:07:59",
        "description": "Bharat Parenterals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in technical momentum, moving from a mildly bearish to a mildly bullish trend. Despite a modest day gain of 2.78%, the stock’s technical indicators present a complex picture, with bullish signals on weekly MACD and Bollinger Bands contrasting with mildly bearish monthly trends and daily moving averages. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term trajectory."
      },
      {
        "title": "Bharat Parenterals Ltd Falls 3.72%: 4 Key Factors Driving the Weekly Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-parenterals-ltd-falls-372-4-key-factors-driving-the-weekly-momentum-shift-3983145",
        "imagepath": "",
        "date": "2026-05-09 13:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Week opens at ₹1,259.45</p>\n                    <p><strong>5 May:</strong> Mixed technical signals amid price momentum shift</p>\n                    <p><strong>7 May:</strong> Upgrade to Sell on technical improvements despite weak fundamentals</p>\n                    <p><strong>8 May:</strong> Technical momentum shifts to mildly bearish; week closes at ₹1,212.65 (-3.72%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,259.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-v..."
      }
    ],
    "total": 420,
    "sid": "1002949",
    "stock_news_url": "https://www.marketsmojo.com/news/bharat-parenterals-1002949"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "21-May-2026",
      "details": "Newspaper publication of Audited Financial Results of the Quarter and Year ended on March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "20-May-2026",
      "details": "Transcript of Earning Conference Call of Q4FY26.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "19-May-2026",
      "details": "Audio Recording of Q4FY26 Earnings Conference Call",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bharat Parenterals Ltd has declared <strong>10%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Bharat Parenterals Gains 10.53%: 2 Key Factors Driving the Week’s Momentum

2026-05-23 13:00:04

Key Events This Week

18 May: Stock closes at Rs.1,266.55 with mixed technical signals amid mildly bullish momentum

19 May: Q4 FY26 results reveal mounting losses and operational turmoil

21 May: Sharp price jump to Rs.1,320.90 (+5.20%) on improving technical outlook

22 May: Week closes at Rs.1,383.95 (+4.77%), outperforming Sensex

Bharat Parenterals Gains 3.25%: 3 Key Factors Driving the Week’s Mixed Momentum

2026-05-16 12:05:50

Key Events This Week

11 May: Stock opens strong at Rs.1,246.35 (+2.78%) amid technical momentum shift

12 May: Technical momentum shifts to mildly bullish despite Sensex decline

14 May: Stock dips 2.03% as technical indicators show mixed signals

15 May: Downgrade to Strong Sell announced; technical momentum shifts sideways

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

21-May-2026 | Source : BSE

Newspaper publication of Audited Financial Results of the Quarter and Year ended on March 31 2026.

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

20-May-2026 | Source : BSE

Transcript of Earning Conference Call of Q4FY26.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

19-May-2026 | Source : BSE

Audio Recording of Q4FY26 Earnings Conference Call

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Bharat Parenterals Ltd has declared 10% dividend, ex-date: 19 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available